GLP-1 Medication Cost Comparison 2026: What You'll Actually Pay

GLP-1 medications have transformed how millions of people approach weight loss and blood sugar management. But for most people considering one, the first question isn't "which is most effective?" It's "how much will this actually cost me?"

The answer depends heavily on your insurance status, which medication you choose, and which cost reduction programs you can access. A medication that costs over $1,000 per month at list price might be $25 to $50 per month with the right coverage.

This guide walks you through what each of the 8 major GLP-1 medications actually costs in different scenarios, and where to find the lowest prices.

The Full Cost Picture

When comparing GLP-1 costs, there are typically three or four price points to consider:

List price is what pharmaceutical companies charge and almost nobody actually pays. It's set high partly for negotiation leverage with insurance companies.

Manufacturer direct-pay programs (like NovoCare for Novo Nordisk medications) bypass insurance and offer lower prices for uninsured patients. These typically cost $150 to $450 per month.

Manufacturer savings cards cap your out-of-pocket cost at $25 per month if you have commercial insurance. The manufacturer pays the rest. (Government insurance patients cannot use these cards.)

Medicare coverage varies by plan. The new GLP-1 Bridge starting July 2026 offers $50 monthly copays for certain medications. The BALANCE Model starting January 2027 changes how Part D covers GLP-1s further.

Comprehensive Pricing by Medication

Medicare Coverage: A New Era Starting July 2026

In January 2027, Medicare Part D transitions to the BALANCE Model, which restructures how GLP-1s are covered and priced. This model aims to increase access further, though specific copay amounts are still being finalized.

Quick Cost Comparison Table

Strategies to Reduce Your Out-of-Pocket Costs

1. Use Manufacturer Savings Cards (Commercial Insurance Only)

If you have commercial (non-government) insurance, a manufacturer savings card is typically the cheapest option at $25 per month. These are available for nearly all major GLP-1 medications. Ask your doctor's office for a card, or download directly from the manufacturer's website. Note: These cannot be used with Medicare, Medicaid, or other government programs.

2. Enroll in Manufacturer Direct Programs

If uninsured, direct programs like NovoCare (Novo Nordisk) and LillyDirect (Eli Lilly) offer uninsured patients prices 60 to 75 percent lower than list price. Eligibility varies, but income limits are often generous. You'll need to enroll once, and then your costs are locked in.

3. Use GoodRx or Similar Discount Pharmacies

For medications without a direct program (or as a backup), GoodRx can significantly undercut list prices. Compare prices across pharmacies because they vary. This works for both insured and uninsured patients, though insured patients usually benefit more from savings cards.

4. Ask About Patient Assistance Programs

Manufacturers offer patient assistance programs for people who don't qualify for insurance coverage. These typically provide free or deeply discounted medication based on income. Common programs include Novo Nordisk's Patient Assistance, Eli Lilly's Lilly Cares, and others. Your doctor's office can help you apply.

5. Consider Generic Options Where Available

Generic liraglutide (Saxenda/Victoza) and potentially other generics are now available at significantly lower prices. Generics work identically to brand names. If you're on a GLP-1 and a generic becomes available, talking to your doctor about switching could reduce costs by 60 to 70 percent.

6. Plan for Medicare in 2026 and Beyond

If you're approaching Medicare age, mark your calendar for the GLP-1 Bridge starting July 2026. If you currently pay out-of-pocket or have expensive Part D coverage, this could slash your costs to $50 per month for Wegovy or Zepbound.

Price Variations and What to Verify

Prices listed in this article reflect typical 2026 pricing and are accurate as of publication. However, pharmaceutical pricing changes frequently. Before starting a medication or switching, always verify current costs with:

• Your pharmacy (prices vary by chain and location)
• Your insurance plan or formulary
• Manufacturer websites for current assistance program details
• GoodRx or similar discount platforms for uninsured options

A few percentage points difference in pharmacy costs or a change in insurance coverage can meaningfully shift which medication is most affordable for you.

Putting It Together: What You'll Realistically Pay

For someone with commercial insurance and a manufacturer savings card, the bottom line is straightforward: $25 per month regardless of which medication you choose. The choice becomes about effectiveness, side effects, and your doctor's recommendation.

For uninsured or underinsured patients, the gap widens. Medications with direct programs (Wegovy, Zepbound) are cheaper than those without (Mounjaro). Generic options like liraglutide offer significant savings. For Medicare patients starting July 2026, the bridge program makes Wegovy and Zepbound very accessible at $50 per month.

The lowest-cost option isn't always obvious without plugging your specific situation into a calculator. That's why your first stop should be verifying current prices with your pharmacy and insurance company.